Diabetes has become one of India’s fastest-growing lifestyle disorders, with millions of new cases emerging every year. Rising stress, unhealthy diet patterns, and sedentary routines make glycemic control a major challenge for patients.
DPP-4 inhibitors like Vildagliptin continue to gain preference due to their strong clinical outcomes and excellent tolerability.
Medpher’s Solution:
✔ Medvilda OD 100, Medvilda 50, Medvilda M50
– Better fasting & post-meal sugar control
– Supports pancreatic β-cell function
– Helps reduce HbA1c levels effectively